Jenny Serra Vinardell, Ph.D.
About Jenny Serra Vinardell, Ph.D.
Jenny Serra Vinardell, Ph.D., is a Research Scientist I at the Broad Institute of MIT and Harvard, specializing in pediatric cancer research through CRISPR technology. With a background that includes a postdoctoral fellowship at the National Institutes of Health and extensive education in genetics, she plays a significant role in advancing treatment discovery for pediatric cancers.
Current Position at Broad Institute
Jenny Serra Vinardell, Ph.D., serves as a Research Scientist I at the Broad Institute of MIT and Harvard. She has held this position since 2022, working on-site in Boston, Massachusetts. In her role, she conducts advanced research in cancer biology, particularly focusing on the application of CRISPR technology to identify potential cancer treatments.
Previous Experience at NIH
Prior to her current role, Vinardell worked as a Postdoctoral Fellow at The National Institutes of Health from 2017 to 2022. During her five years in Bethesda, Maryland, she engaged in significant research projects that contributed to the understanding of cancer mechanisms and treatment strategies.
Educational Background
Vinardell completed her B.S. in Biology at Universitat de Barcelona from 2006 to 2010. She then pursued a Master of Science in Developmental Biology and Genetics from 2010 to 2011 at the same institution. Following her master's degree, she earned her Ph.D. in Genetics from 2011 to 2015, also at Universitat de Barcelona.
Research Initiatives and Contributions
Vinardell plays a key role in the Pediatric Cancer Dependencies Accelerator initiative, which aims to expedite the discovery of treatments for pediatric cancers. She leads a CRISPR genome-wide loss-of-function screening project that focuses on identifying cancer-specific vulnerabilities for targeted therapies. Additionally, she conducts CRISPR-drug perturbational screenings to explore combination therapies and understand mechanisms of cancer drug resistance.
Mentorship and Guidance
In her current role, Vinardell mentors Research Associates, providing guidance in CRISPR-based genome-wide screening techniques. Her mentorship supports the development of skills necessary for conducting cutting-edge research in cancer biology.